Thiazolidinediones but Not Metformin Directly Inhibit the Steroidogenic Enzymes P450c17 and 3β-Hydroxysteroid Dehydrogenase
Open accessThe DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Androgen biosynthesis requires 3beta-hydroxysteroid dehydrogenase type II (3betaHSDII) and the 17alpha-hydroxylase and 17,20-lyase activities of cytochrome P450c17. Thiazolidinedione and biguanide drugs, which are used to increase insulin sensitivity in type 2 diabetes, lower serum androgen concentrations in women with polycystic ovary syndrome. However, it is unclear whether this is secondary to increased insulin sensitivity or to direct effects on steroidogenesis. To investigate potential actions of these drugs on P450c17 and 3betaHSDII, we used "humanized yeast" that express these steroidogenic enzymes in microsomal environments. The biguanide metformin had no effect on either enzyme, whereas the thiazolidinedione troglitazone inhibited 3betaHSDII (K(I) = 25.4 +/- 5.1 microm) and both activities of P450c17 (K(I) for 17alpha-hydroxylase, 8.4 +/- 0.6 microm; K(I) for 17,20-lyase, 5.3 +/- 0.7 microm). The action of troglitazone on P450c17 was competitive, but it was mainly a noncompetitive inhibitor of 3betaHSDII. The thiazolidinediones rosiglitazone and pioglitazone exerted direct but weaker inhibitory effects on both P450c17 and 3betaHSDII. These differential effects of the thiazolidinediones do not correlate with their effects on insulin sensitivity, suggesting that distinct regions of the thiazolidinedione molecule mediate these two actions. Thus, thiazolidinediones inhibit two key enzymes in human androgen synthesis contributing to their androgen-lowering effects, whereas metformin affects androgen synthesis indirectly, probably by lowering circulating insulin concentrations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![FIG. 2 Effect of metformin and troglitazone on the differential activities of human P450c17. A , 17 a -hydroxylase activity. Microsomes prepared from yeast coexpressing human P450c17 and human P450 oxidoreductase were incubated with 1 m M [ 14 C]progesterone ( Prog ) and 0-100 m M metformin ( MET ) and troglitazone ( TRO ). 17 a -Hydroxylase activity was assessed as the conversion rate of [ 14 C]progesterone to 17OHP. B , 17,20-lyase activity. Microsomes coexpressing P450c17 and OR were incubated with 1 m M 17-Preg and 0-100 m M metformin and troglitazone. 17,20-Lyase activity was assessed as the conversion rate of [ 3 H]17 a -hydroxypregnenolone to DHEA. Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/4221417a95fd41fd829b22d85a3904cd/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-2.png)
![FIG. 3 Kinetic analysis of the mode of inhibition of P450c17 activities by troglitazone ( TRO ). Lineweaver-Burk plots of 17 a -hydroxylase activity ( A ) and 17,20-lyase activity ( B ) and Dixon plot of 17 a -hydroxylase activity ( C ) in the absence and presence of troglitazone (0-20 m M) and with 0.5, 1, 2, and 4 m M [ 14 C]progesterone ( Prog ) and 17-Preg for the assessment of 17 a -hydroxylase and 17,20-lyase activity, respectively. Incubations were carried out with yeast microsomes (40 m g of total protein) coexpressing human P450c17 and human P450 oxidoreductase. Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/0a2f41b8bc8041eeafe30abc2029b10d/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-3.png)
![FIG. 4 Inhibition of 17 a -hydroxylase activity by troglitazone ( TRO ) in whole cells ( solid line ) and in yeast microsomes ( dotted line ). COS-1 cells transiently expressing human P450c17 and yeast microsomes expressing both P450c17 and P450 oxidoreductase were incubated with [ 14 C]progesterone ( Prog ), and 17 a -hydroxylase activity was determined as the conversion rate of [ 14 C]progesterone to 17OHP. Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/00ca13bafc4b44c9ba9879e6bf50d444/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-4.png)


![FIG. 6 Kinetic analysis of the mode of inhibition of 3 b HSDII activity by troglitazone ( TRO ). Lineweaver-Burk plot ( A ) and Dixon plot ( B ) of 3 b HSDII activity. Incubations were carried out with yeast microsomes (40 m g total protein) expressing human 3 b HSDII in the absence and presence of troglitazone (0-60 m M) with 1, 5, 10, and 20 m M [ 14 C]pregnenolone ( Preg ). Each data point represents the mean 6 S.D. of triplicate determinations.](https://figures.cochat.ai/paper-figures/3eb67229e31543189611c7633bbcc3df/thiazolidinediones-but-not-metformin-directly-inhibit-the-steroidogenic-enzymes-figure-6.png)
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lehmann, J. M., Moore, L. B., Smith-Oliver, T. A., Wilkison, W. O., Willson, T. M., & Kliewer, S. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.22.12953 · Cited by 3,625
Improved method for high efficiency transformation of intact yeast cells
Gietz, D., Jean, A. S., Woods, R. A., & Schiestl, R. H. (1992) · Nucleic Acids Research · doi:10.1093/nar/20.6.1425 · Cited by 3,261
Insulin Resistance and the Polycystic Ovary Syndrome: Mechanism and Implications for Pathogenesis*
Dunaif, A. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.6.0318 · Cited by 2,458
OWEN, M. R., DORAN, E., & HALESTRAP, A. P. (2000) · Biochemical Journal · doi:10.1042/bj3480607 · Cited by 2,157
Roles of PPARs in health and disease
Kersten, S., Desvergne, B., & Wahli, W. (2000) · Nature · doi:10.1038/35013000 · Cited by 1,956
PPAR-gamma: adipogenic regulator and thiazolidinedione receptor.
Spiegelman, B. M. (1998) · Diabetes · doi:10.2337/diabetes.47.4.507 · Cited by 1,730
Aromatase Cytochrome P450, The Enzyme Responsible for Estrogen Biosynthesis*
SIMPSON, E. R., MAHENDROO, M. S., MEANS, G. D., KILGORE, M. W., HINSHELWOOD, M. M., GRAHAM-LORENCE, S., AMARNEH, B., ITO, Y., FISHER, C. R., MICHAEL, M. D., et al. (1994) · Endocrine Reviews · doi:10.1210/edrv-15-3-342 · Cited by 1,537
El-Mir, M.-Y., Nogueira, V., Fontaine, E., Avéret, N., Rigoulet, M., & Leverve, X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.223 · Cited by 1,399
Molecular biology of steroid hormone synthesis
MILLER, W. L. (1988) · Endocrine Reviews · doi:10.1210/edrv-9-3-295 · Cited by 1,397
Self-citationEfficacy of Metformin in Patients with Non-Insulin-Dependent Diabetes Mellitus
DeFronzo, R. A., & Goodman, A. M. (1995) · New England Journal of Medicine · doi:10.1056/nejm199508313330902 · Cited by 1,368
Kiddy, D. S., Hamilton‐Fairley, D., Bush, A., Short, F., Anyaoku, V., Reed, M. J., & Franks, S. (1992) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1992.tb02909.x · Cited by 921
Velazquez, E. M., Mendoza, S., Hamer, T., Sosa, F., & Glueck, C. J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90209-7 · Cited by 865
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
[6] Yeast expression of animal and plant P450s in optimized redox environments
Pompon, D., Louerat, B., Bronine, A., & Urban, P. (1996) · Methods in Enzymology · doi:10.1016/s0076-6879(96)72008-6 · Cited by 653
Willson, T. M., Cobb, J. E., Cowan, D. J., Wiethe, R. W., Correa, I. D., Prakash, S. R., Beck, K. D., Moore, L. B., Kliewer, S. A., & Lehmann, J. M. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm950395a · Cited by 638
Cytochrome b 5 Augments the 17,20-Lyase Activity of Human P450c17 without Direct Electron Transfer
Auchus, R. J., Lee, T. C., & Miller, W. L. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.6.3158 · Cited by 541
Self-citationTreatment of insulin resistance with peroxisome proliferator–activated receptor γ agonists
Olefsky, J. M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10843 · Cited by 537
Dunaif, A., Scott, D., Finegood, D., Quintana, B., & Whitcomb, R. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.9.8784087 · Cited by 524
EHRMAN, D. A., BARNES, R. B., & ROSENFIELD, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 502
Ehrmann, D. A., Schneider, D. J., Sobel, B. E., Cavaghan, M. K., Imperial, J., Rosenfield, R. L., & Polonsky, K. S. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.7.4069 · Cited by 461
Chung, B. C., Picado-Leonard, J., Haniu, M., Bienkowski, M., Hall, P. F., Shively, J. E., & Miller, W. L. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.2.407 · Cited by 444
Self-citationMolecular Endocrinology of Hydroxysteroid Dehydrogenases*
Penning, T. M. (1997) · Endocrine Reviews · doi:10.1210/edrv.18.3.0302 · Cited by 438
Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 401
Berger, J., Bailey, P., Biswas, C., Cullinan, C. A., Doebber, T. W., Hayes, N. S., Saperstein, R., Smith, R. G., & Leibowitz, M. D. (1996) · Endocrinology · doi:10.1210/endo.137.10.8828476 · Cited by 391
Expression of Bovine 17α-Hydroxylase Cytochrome P-450 cDNA in Nonsteroidogenic (COS 1) Cells
Zuber, M. X., Simpson, E. R., & Waterman, M. R. (1986) · Science · doi:10.1126/science.3535074 · Cited by 388
Nestler, J. E., & Jakubowicz, D. J. (1997) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.82.12.4431 · Cited by 368
Rhéaume, E., Lachance, Y., Zhao, H.-F., Breton, N., Dumont, M., Launoit, Y. D., Trudel, C., Luu-The, V., Simard, J., & Labrie, F. (1991) · Molecular Endocrinology · doi:10.1210/mend-5-8-1147 · Cited by 362
Analysis of enzyme kinetic data
(1995) · Biochemical Education · doi:10.1016/0307-4412(95)90181-7 · Cited by 324
Crave, J. C. (1995) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.80.7.2057 · Cited by 302
Nakajin, S., Shively, J., Yuan, P.-M., & Hall, P. F. (1981) · Biochemistry · doi:10.1021/bi00517a014 · Cited by 293
Camp, H. S., Li, O., Wise, S. C., Hong, Y. H., Frankowski, C. L., Shen, X., Vanbogelen, R., & Leff, T. (2000) · Diabetes · doi:10.2337/diabetes.49.4.539 · Cited by 224
Cox, P. J., Ryan, D. A., Hollis, F. J., Harris, A.-M., Miller, A. K., Vousden, M., & Cowley, H. (2000) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)15347-0 · Cited by 208
Geller, D. H., Auchus, R. J., & Miller, W. L. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.1.0219 · Cited by 183
Self-citationLin, D. (1993) · Endocrinology · doi:10.1210/en.132.6.2498 · Cited by 175
Self-citationSambol, N. C., Chiang, J., O'Conner, M., Liu, C. Y., Lin, E. T., Goodman, A. M., Benet, L. Z., & Karam, J. H. (1996) · The Journal of Clinical Pharmacology · doi:10.1177/009127009603601105 · Cited by 167
Expression and Detection of Inducible Nitric Oxide Synthase in Experimental Models of Inflammation
Lüss, H., Nüssler, N. C., Beger, H. G., & Nussler, A. K. (1996) · Methods · doi:10.1006/meth.1996.0078 · Cited by 157
Thomas, J. L., Myers, R. P., & Strickler, R. C. (1989) · Journal of Steroid Biochemistry · doi:10.1016/0022-4731(89)90296-3 · Cited by 148
Missense mutation serine106—-proline causes 17 alpha-hydroxylase deficiency
Lin, D., Harikrishna, J. A., Moore, C. C., Jones, K. L., & Miller, W. L. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)98506-6 · Cited by 135
Self-citationMarca, A. L., Egbe, T. O., Morgante, G., Paglia, T., Ciani, A., & Leo, V. D. (2000) · Human Reproduction · doi:10.1093/humrep/15.1.21 · Cited by 119
An efficient chloramphenicol-resistance marker for Saccharomyces cerevisiae and Escherichia coli
Hadfield, C., Cashmore, A. M., & Meacock, P. A. (1986) · Gene · doi:10.1016/0378-1119(86)90249-0 · Cited by 74
Lee, T. C., Miller, W. L., & Auchus, R. J. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.6.5646 · Cited by 71
Self-citationSteady‐State Pharmacokinetics and Dose Proportionality of Troglitazone and Its Metabolites
Loi, C., Alvey, C. W., Vassos, A. B., Randinitis, E. J., Sedman, A. J., & Koup, J. R. (1999) · The Journal of Clinical Pharmacology · doi:10.1177/00912709922008533 · Cited by 54
Research works printed but not linked: 11
- Penning, 1997, Endocr. Rev., 18, 281
- Simpson, 1994, Endocr. Rev., 15, 342
- Lin, 1993, Endocrinology, 132, 2498, 10.1210/endo.132.6.8504753 · doi:10.1210/endo.132.6.8504753 · Paper page
- Dunaif, 1997, Endocr. Rev., 18, 774
- Dunaif, 1996, J. Clin. Endocrinol. Metab., 81, 3299
- Ehrmann, 1997, J. Clin. Endocrinol. Metab., 82, 2108
- Lee, 1999, J. Clin. Endocrinol. Metab., 84, 2104
- Nestler, 1997, J. Clin. Endocrinol. Metab., 82, 4075
- Crave, 1995, J. Clin. Endocrinol. Metab., 80, 2057
- Maeshiba, 1997, Arzneim. Forsch., 47, 29
- Cox, 2000, Drug Metab. Dispos., 28, 772
Cited by
The Molecular Biology, Biochemistry, and Physiology of Human Steroidogenesis and Its Disorders
Miller, W. L., & Auchus, R. J. (2011) · Endocrine Reviews · doi:10.1210/er.2010-0013 · Cited by 2,458
Self-citationDiamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
10.1016/b978-1-4160-2911-3.50026-1
(2000) · CrossRef Listing of Deleted DOIs · doi:10.1016/b978-1-4160-2911-3.50026-1 · Cited by 554
Thiazolidinedione Use and Bone Loss in Older Diabetic Adults
Schwartz, A. V., Sellmeyer, D. E., Vittinghoff, E., Palermo, L., Lecka-Czernik, B., Feingold, K. R., Strotmeyer, E. S., Resnick, H. E., Carbone, L., Beamer, B. A., et al. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2226 · Cited by 500
“TZDs also decrease testosterone levels in women with polycystic ovary syndrome (24, 25).”
BackgroundPalomba, S., Falbo, A., Zullo, F., & Orio, F. (2009) · Endocrine Reviews · doi:10.1210/er.2008-0030 · Cited by 426
Metadata
- Authors
- Arlt, W., Auchus, R. J., & Miller, W. L.
- Affiliations
- University of California, San Francisco (US)
- The University of Texas Southwestern Medical Center (US)
- Corresponding author
- Miller, Walter L.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 276
- Issue
- 20
- Pages
- 16767-16771
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2050353370
- Semantic Scholar
- 882bbddf93d24e3507b22bb163aad3ac5fa2f1ce
- Cited by
- 157
- References
- 42
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 1 · 2023: 3 · 2022: 7 · 2021: 2 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 3 · 2013: 7 · 2012: 7
- FWCI
- 12.52
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 7088 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion)
- Spiral (Imperial College London) (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft
- National Institutes of Health (5k08dk002387-06)
- National Institute of Diabetes and Digestive and Kidney Diseases (K08 DK 02387, R01DK037922, R01DK37922)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (U54-HD34449, U54HD034449)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Pharmacogenetics and Drug Metabolism
- Keywords
- thiazolidinediones, metformin, P450c17, steroidogenesis, androgen production, troglitazone, rosiglitazone, pioglitazone, polycystic ovary syndrome, enzyme inhibition, insulin sensitivity, type 2 diabetes
- MeSH terms
- Pioglitazone, Troglitazone, Biguanides, Chromans, Cloning, Molecular, Humans, Kinetics, Metformin, Recombinant Proteins, Saccharomyces cerevisiae, Steroid Hydroxylases, Steroid 17-alpha-Hydroxylase, Thiazoles, 3-Hydroxysteroid Dehydrogenases, Thiazolidinediones
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.